Want to see AU:CSX full AI Analyst Report?
Top Page
CleanSpace Holdings Ltd.
(Sydney:CSX)
Select Model
Select Model
Rating:50Neutral
Price Target:
AU$0.37
▼(-13.10% Downside)
Action:Reiterated
Date:09/08/26
The score is primarily held back by weak financial performance (ongoing losses, volatile margins, and a return to negative free cash flow in 2026) despite a relatively low-debt balance sheet. Technicals provide some support with bullish short-term trend and positive MACD, but overbought signals and a weak longer-term trend temper that. Valuation is constrained by a negative P/E and lack of dividend yield.
Positive Factors
Low leverage
Very low leverage gives CleanSpace greater financial flexibility than a heavily indebted business. A sizeable equity base can help absorb operating volatility and preserve capacity to invest in product development, sales execution, or market expansion while profitability remains under development.
Negative Factors
Persistent losses
CleanSpace has not yet converted its revenue base into sustainable earnings, as losses and negative margins continue through the latest periods. Persistent unprofitability limits internally funded growth, weakens returns on equity, and leaves execution on cost control central to the investment case.
Read all positive and negative factors
Positive Factors
Negative Factors
Low leverage
Very low leverage gives CleanSpace greater financial flexibility than a heavily indebted business. A sizeable equity base can help absorb operating volatility and preserve capacity to invest in product development, sales execution, or market expansion while profitability remains under development.
Read all positive factors
CleanSpace Holdings Ltd. (CSX) vs. iShares MSCI Australia ETF (EWA)
Market Cap
AU$28.97M
Dividend YieldN/A
Average Volume (3M)71.66K
Price to Earnings (P/E)―
Beta (1Y)0.78
Revenue Growth0.29%
EPS Growth-148.39%
CountryAU
Employees53
SectorHealthcare
Sector Strength45
IndustryMedical - Devices
Share Statistics
EPS (TTM)-0.02
Shares Outstanding79,364,860
10 Day Avg. Volume75,588
30 Day Avg. Volume71,662
Financial Highlights & Ratios
PEG Ratio-0.16
Price to Book (P/B)1.70
Price to Sales (P/S)1.59
P/FCF Ratio-221.52
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.01
Revenue Forecast (FY)AU$24.40M
CleanSpace Holdings Ltd. Business Overview & Revenue Model
Company Description
CleanSpace Holdings Limited is a global enterprise focused on the design, manufacturing, and sale of personal respiratory protective equipment and related services. The company's advanced solutions serve healthcare professionals and a wide array o...
How the Company Makes Money
CleanSpace generates revenue primarily from the sale of its respiratory protection products. Key revenue streams typically include (1) hardware sales of its PAPR units and associated components, and (2) ongoing consumables and replacement items us...
CleanSpace Holdings Ltd. Financial Statement Overview
Summary
Income Statement
32
Negative
Balance Sheet
67
Positive
Cash Flow
44
Neutral
| Breakdown | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 19.82M | 19.76M | 15.72M | 12.09M | 13.36M |
| Gross Profit | 4.07M | 14.78M | 11.36M | -5.16M | 9.75M |
| EBITDA | -1.60M | -824.55K | -3.49M | -10.55M | -14.10M |
| Net Income | -1.25M | -478.28K | -3.13M | -8.13M | -11.28M |
Balance Sheet | |||||
| Total Assets | 23.46M | 27.57M | 26.05M | 28.98M | 38.36M |
| Cash, Cash Equivalents and Short-Term Investments | 10.08M | 10.47M | 9.76M | 12.16M | 24.30M |
| Total Debt | 1.45M | 4.54M | 3.45M | 4.00M | 4.13M |
| Total Liabilities | 4.96M | 8.41M | 6.95M | 7.02M | 8.60M |
| Stockholders Equity | 18.50M | 19.16M | 19.10M | 21.96M | 29.75M |
Cash Flow | |||||
| Free Cash Flow | -141.86K | 1.01M | -1.76M | -11.97M | -13.60M |
| Operating Cash Flow | 69.20K | 1.11M | -1.73M | -11.96M | -13.00M |
| Investing Cash Flow | -622.07K | -778.38K | 2.00M | 7.06M | -628.00K |
| Financing Cash Flow | -254.56K | -559.87K | -637.10K | -211.49K | -357.95K |
CleanSpace Holdings Ltd. Technical Analysis
Neutral
0.42
Price Trends
0.40
Negative
0.40
Positive
0.49
Negative
Market Momentum
>-0.01
Positive
49.30
Neutral
13.64
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:CSX, the sentiment is Neutral. The current price of 0.42 is above the 20-day moving average (MA) of 0.41, above the 50-day MA of 0.40, and below the 200-day MA of 0.49, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 49.30 is Neutral, neither overbought nor oversold. The STOCH value of 13.64 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for AU:CSX.
CleanSpace Holdings Ltd. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | AU$46.26B | 21.88 | 23.88% | 1.03% | 4.74% | 4.44% | |
61 Neutral | AU$46.94M | 209.09 | 0.93% | ― | 18.54% | ― | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
50 Neutral | AU$28.97M | -25.65 | -6.27% | ― | 0.29% | -148.39% | |
45 Neutral | AU$15.34M | -4.29 | -48.97% | ― | 40.65% | 45.45% | |
44 Neutral | AU$60.35M | -3.00 | -62.14% | 0.64% | 12.05% | -31.71% | |
43 Neutral | AU$10.53M | -1.19 | -188.06% | ― | 15.58% | 37.17% |
* Healthcare Sector Average
AU:CSX
CleanSpace Holdings Ltd.
0.40
-0.37
-48.03%
AU:CMP
Compumedics Limited
0.23
-0.05
-16.36%
AU:AT1
Atomo Diagnostics Ltd.
0.02
>-0.01
-10.00%
AU:CYC
Cyclopharm Limited
0.48
-0.40
-45.45%
AU:MX1
Micro-X Ltd.
0.02
-0.07
-81.11%
AU:RMD
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
32.04
-8.47
-20.91%
CleanSpace Holdings Ltd. Corporate Events
CleanSpace publishes FY26 results presentation with investor guidance and disclaimers
Aug 27, 2026
CleanSpace Holdings Ltd has released its FY26 results presentation for the year ended 30 June 2026, outlining financial information prepared in accordance with IFRS and supplemented by non-IFRS metrics such as EBITDA and free cash flow to clarify ...
CleanSpace Confirms 2026 Corporate Governance Compliance Under ASX Rules
Aug 27, 2026
CleanSpace Holdings Ltd., an ASX-listed provider of industrial respiratory protection technology, has confirmed its corporate governance framework for the financial year ended 30 June 2026. The company operates under the ASX Corporate Governance C...
CleanSpace Posts Wider Loss Despite Stable Revenue in 2026
Aug 27, 2026
CleanSpace Holdings Limited has reported a modest 0.3% increase in revenue to $19.8 million for the year ended 30 June 2026, but a sharply wider net loss after tax of $1.25 million, up 160.8% from the prior year. Basic and diluted earnings per sha...
CleanSpace Launches 10% On-Market Share Buyback to Signal Confidence in Growth
Aug 27, 2026
CleanSpace Holdings Ltd., an Australian maker of premium respiratory protection solutions for industrial and healthcare users, builds on two decades of technology-driven advances in protective equipment. Backed by biomedical engineering expertise,...
CleanSpace Wins Record A$1.9m Order From Global Miner in Indonesia
Aug 9, 2026
CleanSpace Holdings has secured a new A$1.9 million order from its Indonesian distributor PT Lasindo Jayabersama to supply powered air purifying respirators to a global copper and gold miner operating in Indonesia. The deal, to be fulfilled in the...
CleanSpace reports lapse of 78,000 restricted share awards
Aug 7, 2026
CleanSpace Holdings Ltd., listed on the ASX under ticker CSX, has updated the market on a change to its issued capital structure. The company reported the lapse of restricted share awards, reflecting adjustments to its equity-based incentives.The ...
CleanSpace Cancels 63,333 Lapsed Restricted Share Awards
Aug 3, 2026
CleanSpace Holdings has announced the cessation of 63,333 restricted share awards, following the lapse of conditional rights that could not be satisfied. The move slightly reduces the company’s issued capital linked to these awards and may i...
CleanSpace Sets Timetable for FY26 Results and AGM
Jul 29, 2026
CleanSpace Holdings Limited will release its audited financial results for the year ended 30 June 2026 on 28 August 2026, accompanied by a video and webcast briefing for investors and analysts. The company has also set key dates for governance eve...
CleanSpace seeks ASX quotation for new share issuance
Jun 26, 2026
CleanSpace Holdings has applied for quotation on the ASX of 113,334 new ordinary fully paid shares, issued on June 26, 2026. The move marginally increases the company’s quoted share capital, providing additional tradable stock for investors ...
CleanSpace Sets New Securities Trading Policy for Insiders
Jun 23, 2026
CleanSpace Holdings has introduced a securities trading policy, effective 1 July 2026, that governs how directors, senior management, and other designated persons may deal in the company’s securities. The policy clarifies that it is not inte...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.